ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)

Completed

Conditions studied: Myocardial Ischemia

In brief

The purpose of this 12-month, observational, follow-up study is to collect additional data (by telephone contact) with which to assess the efficacy, safety, and effects of intramyocardial injections of adult autologous CD34+ cells on quality of life (QoL) in subjects with chronic refractory myocardial ischemia. No treatments will be administered during this study. However, the investigators and other study site personnel and the subjects will remain blinded to the treatment assignments from the core therapeutic study (# 24779) so as to provide a total of 24 months of blinded data.

Key facts

Study ID

NCT00545610

Run by

Lisata Therapeutics, Inc.

People needed

150

Starts

2007-10-01

Expected to finish

2010-06-01

Last updated by the study team

2018-11-28

Who can join

Age: 21 and older, up to 81. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have received treatment with Auto-CD34+ cells or with placebo and who have completed the final study visit (Month 12) of the core therapeutic study 24779
• Subjects who are willing to comply with the specified follow-up evaluations in this study and to provide written informed consent to participate in this study

Where it is running

• Cardiology, PC — Birmingham, Alabama, United States
• Mayo Clinic Hospital — Phoenix, Arizona, United States
• Scripps Green Hospital / Scripps Clinical Hospital — La Jolla, California, United States
• Stanford University Hospital and Clinics — Stanford, California, United States
• Washington Hospital Center — Washington D.C., District of Columbia, United States
• Holy Cross Hospital — Fort Lauderdale, Florida, United States
• University of Florida — Gainesville, Florida, United States
• University of Florida Health Science Center — Jacksonville, Florida, United States
• Cardiovascular Institute Florida Hospital — Orlando, Florida, United States
• The Medical Group of St. Joseph´s — Atlanta, Georgia, United States
• Northwestern University Medical School — Chicago, Illinois, United States
• Rush University Medical Center — Chicago, Illinois, United States
• University of Iowa — Iowa City, Iowa, United States
• Caritas St. Elizabeth´s Medical Center — Boston, Massachusetts, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Minneapolis Heart Institute — Minneapolis, Minnesota, United States
• Cornell University — New York, New York, United States
• New York Presbyterian Hospital — New York, New York, United States
• The Lindner Clinical Trial Center — Cincinnati, Ohio, United States
• University of Cincinnati Medical Center — Cincinnati, Ohio, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• University of Wisconsin Medical School — Madison, Wisconsin, United States
• Heart Care Associates, LLC — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.